Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$84.64
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | LLY Avg Daily Volume: 3,284,800
Last Update: 09/25/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 15.08%
Open: $0.00
Previous Close: $84.64
52 Week Range: $64.18 - $86.72
Oustanding Shares: 1,100,988,944
Market Cap: 92,383,982,291
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 10 10
Moderate Buy 1 1 1 1
Hold 6 6 4 4
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
Mean Rec. 2.24 2.06 1.81 1.81
Latest Dividend: 0.52
Latest Dividend Yield: 2.48%
Dividend Ex-Date: 08/11/17
Price Earnings Ratio: 36.17
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
36.17 36.30 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.89% 4.29% 29.06%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.30 -0.10 -0.03
Net Income 13.70 -0.40 -0.16
EPS 14.20 -0.40 -0.16
Earnings for LLY:
EBITDA 5.34B
Revenue 21.22B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.03 $1.03 $4.15 $4.57
Number of Analysts 7 6 10 10
High Estimate $1.11 $1.08 $4.19 $4.83
Low Estimate $0.98 $1.00 $4.08 $4.38
Prior Year $0.88 $0.95 $3.52 $4.15
Growth Rate (Year over Year) 17.05% 8.77% 17.93% 10.12%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The charts don't look positive for drug company Eli Lilly.
There's one going on now.
The path of least resistance for LLY is lower.

Some Weak Names Today Real Money Pro($)

An old trading dictim is that you might consider selling or shorting stocks that are in the red when the market is broadly in the green (and vice…

Here's What Up (and Down) Real Money Pro($)

After 90 minutes of trading here are some market features:   * Bonds are getting schmeissed. The 10-year U.S. note yield is close to…

Biotech Sees Sharp Reversal Real Money Pro($)

Biotech, as represented by iShares Nasdaq Biotechnology Index Fund (IBB) , universally beloved by technicians and "talking heads" has just suff…
Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.
Days like this remind you why you stay in.
It just isn't as useful or descriptive right now.
A rotation that started as the minor chord of the rotational symphony and is now the major one.

Columnist Conversations

TheStreet's Scott Gamm has Jordan Belfort on-camera today. Any questions you may have for the Wolf of Wall Str...
How about that pullback...
there is some very heavy selling today and poor price action in Facebook today.  in the first hour the st...
Stock has been roasted last five trading sessions. Time to rotate into Ford ahead of big CEO long-term plan re...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.